Abrupt termination of vitamin C from ICU patients may increase mortality: secondary analysis of the LOVIT trial

Background The LOVIT trial examined the effect of vitamin C on sepsis patients, and concluded that in adults with sepsis receiving vasopressor therapy in the ICU, those who received 4-day intravenous vitamin C had a higher risk of death or persistent organ dysfunction at 28 days than those who recei...

Ausführliche Beschreibung